Skip to main content

Yevgeny Brudno, PhD, is a UNC Lineberger Comprehensive Cancer Center member. The Brudno Lab develops technologies to deliver drugs to disease sites using cutting-edge chemical, biomaterial and nanomedicine technologies.

Associate Professor, Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy
Joint Biomedical Engineering Department, UNC and NCSU
UNC-Chapel Hill and NC State University
Molecular Therapeutics

Area of Interest

The Brudno lab focuses on exploiting cutting edge chemistry and material science technologies to understand physiological responses during disease and fulfill critical unmet needs in the clinic. Our group develops new biomaterials for therapeutic cell production and delivery and drug delivery, with a focus on cancer immunotherapy and CAR T cell therapy. Our lab’s research is rooted in the belief that advances in chemistry and the basic molecular sciences can generate meaningful change in how therapies are designed, produced, and administered.

Find publications on PubMed

Awards and Honors

  • University Faculty Scholar
  • Goodnight Early Career Innovator Award
  • Outstanding Teacher Award
  • NCI MERIT Award

News and Stories

View all related posts

Headshot of Yevgeny Brudno.